Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

22. Juli 2016 02:30 ET | Quelle: NICOX SA

Press Release concerning latanoprostene bunod

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press Release concerning latanoprostene...
21. Juli 2016 15:27 ET | Quelle: DIAGNOS Inc.

DIAGNOS Inc. Announces Rights Offering

BROSSARD, QUÉBEC--(Marketwired - July 21, 2016) - Diagnos Inc. (TSX VENTURE:ADK) ("Diagnos" or the "Corporation") announces that it will be offering rights ("Rights") to holders...
21. Juli 2016 07:00 ET | Quelle: Applied Genetic Technologies Corporation

AGTC Announces Presentations in Upcoming Scientific Conferences

GAINESVILLE, Fla. and CAMBRIDGE, Mass., July 21, 2016 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a clinical stage biotechnology company developing adeno-associated...
20. Juli 2016 08:00 ET | Quelle: pSivida Corp

Data Shows pSivida’s Tethadur™ Provides Prolonged, Sustained Release of Avastin® With High Drug Efficacy

WATERTOWN, Mass., July 20, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for eye diseases,...
19. Juli 2016 06:24 ET | Quelle: Research and Markets

Global Semiconductor Laser Treatment Market 2016-2020 with Cutera, Cynosure, Lumenis, Syneron Medical & Topcon Dominating

Dublin, July 19, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Semiconductor Laser Treatment Market 2016-2020" report to their offering. ...
14. Juli 2016 11:00 ET | Quelle: pSivida Corp

Investigator-Sponsored Phase 2 Study Results Show pSivida’s Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve

WATERTOWN, Mass., July 14, 2016 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug delivery products primarily for eye diseases,...
13. Juli 2016 12:00 ET | Quelle: Nextech

Nextech Introduces NexCloud: Cloud-Based Solution Offers Rapid Implementation and Monthly Subscription Pricing

TAMPA, FL--(Marketwired - July 13, 2016) - Nextech, a leading provider of specialty-focused healthcare technology solutions for physician practices, today announced the launch of NexCloud, a...
13. Juli 2016 08:30 ET | Quelle: SCYNEXIS, Inc.

SCYNEXIS, Inc. Announces Sale of Cyclophilin Inhibitor Assets to Cypralis Limited

JERSEY CITY, N.J., July 13, 2016 (GLOBE NEWSWIRE) -- Drug development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced that the Company has entered into an Asset Purchase agreement with UK-based...
12. Juli 2016 16:01 ET | Quelle: TearLab Corporation

TearLab Corporation Comments on Shire plc FDA Approval of Xiidra™ (lifitegrast ophthalmic solution) 5%

SAN DIEGO, July 12, 2016 (GLOBE NEWSWIRE) -- TearLab Corporation (NASDAQ:TEAR) (TSX:TLB) (“TearLab” or the “Company”), a company that develops and markets point of care ophthalmic in-vitro...
11. Juli 2016 08:30 ET | Quelle: Coherus BioSciences, Inc.

Coherus Announces Positive Topline Results for CHS-1701 (Pegfilgrastim Biosimilar Candidate) Pharmacokinetic and Pharmacodynamic Biosimilarity Study

REDWOOD CITY, Calif., July 11, 2016 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (NASDAQ:CHRS), a leading global biosimilars company with late-stage clinical products, today reported topline...

Vorherige Seite

Nächste Seite